The pharmacologically delivered rIL-18 to CD2-IL-5 mice transformed naïve eosinophils to pathogenic intraepithelial eosinophilia and degranulating extracellular eosinophilic granules. The gene discussed is CD2; the disease is Increased total eosinophil count.